Login   |  
Contact   |  

Tech IP counsel wary of overreaching Amgen v Sanofi ruling

In-house tech sources say Amgen v Sanofi has the potential to stifle their prosecution and litigation strategies if SCOTUS’s decision is too broad

View Full Article

Related Articles

News Feed

Roundup Ready 2 Patent Litigation

Bayer CropScience v. Pierce, et al. (E.D. Mo 2023) Bayer and its subsidiary Monsanto have filed a new set of…
Learn More
News Feed

This week on MIP: DABUS appeal, ‘secret’ commissions

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere…
Learn More
Generated by Feedzy